The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

Facing a painful and distracting case of dry eye, a reporter went looking for treatments. What she found was surprising.

Excessive use of digital devices and mental health issues can both contribute to the development of dry eye syndrome.

Having both aqueous-deficient and evaporative dry eye, corneal pain, or a history of dry eye treatment can worsen quality of life.